Differences

This shows you the differences between two versions of the page.

--- home:diseases:ms [01.18.2019] – [Member experience] sallieq
+++ home:diseases:ms [01.28.2019] – [Recent Research] sallieq
@@ Line 191: / Line 191: @@
-This review focuses on four main themes influencing current understanding of thermoregulatory dysfunction in MS   (({{pubmed>long:30459034}}))
+ This review focuses on four main themes influencing current understanding of thermoregulatory dysfunction in MS   (({{pubmed>long:30459034}}))
+[[https://www.cell.com/neuron/fulltext/S0896-6273(18)31123-1?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627318311231%3Fshowall%3Dtrue|from Misgeld, Kerschensteiner. et al]]
+    •    Cytoplasmic calcium accumulations predict axon degeneration in neuroinflammation
+    •    Release from the axoplasmic reticulum does not explain calcium accumulations
+    •    Calcium influx from the extracellular space drives axon degeneration
+    •    Nanoscale ruptures allow entry of calcium across the axonal plasma membrane
 ===== Member experience =====
@@ Line 215: / Line 221: @@
 -Limburg
 </blockquote>
+<blockquote>On starting MP // Yomi posted// I was diagnosed with Sarcoidodis in 2001. I have had manifestaions obviously in the lungs but later in the eyes (uveitis) the skin (granluoma) and most recently in the nervous system (neuropathy).  I've got a decent case of lupus pernio pretty much all over my body. So these symptoms along with the neuropathy are taking its time as expected.
+(//questioned after 8 years how the lupus has responded//)
+It has some. The raised bumps on my face used to have a dark colored center. Now the bumps no longer have the dark colored center and aren't as swollen.</blockquote>
 These also present the treatment of Multiple Sclerosis with the Marshall Protocol.

home/diseases/ms.txt · Last modified: 09.14.2022 by 127.0.0.1